| Product Code: ETC7550864 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India Pharmacovigilance Market is witnessing significant growth due to factors such as increasing awareness about drug safety, rising incidences of adverse drug reactions, and the growing pharmaceutical industry in the country. The market is driven by the implementation of stringent regulations by regulatory authorities, such as the Central Drugs Standard Control Organization (CDSCO), to ensure the safety and efficacy of drugs. Additionally, the outsourcing trend in pharmacovigilance services by pharmaceutical companies to reduce costs and focus on core competencies is boosting market growth. Key players in the India Pharmacovigilance Market include Cognizant, Accenture, and IQVIA, offering services such as case processing, adverse event reporting, signal detection, and risk management. Overall, the market is poised for further expansion with the increasing emphasis on patient safety and regulatory compliance in the pharmaceutical sector.
The India Pharmacovigilance Market is seeing significant growth due to increasing regulatory requirements, rising demand for drug safety monitoring, and a growing focus on patient safety. Key trends include the adoption of advanced technologies like artificial intelligence and big data analytics to enhance pharmacovigilance processes, the outsourcing of pharmacovigilance services to specialized vendors for cost-efficiency, and the incorporation of real-world evidence in drug safety monitoring. Opportunities in the market lie in the expansion of pharmacovigilance activities by pharmaceutical companies, the development of robust reporting systems to comply with regulatory standards, and the increasing awareness among healthcare professionals and patients about the importance of pharmacovigilance in ensuring the safety and efficacy of medications. Overall, the India Pharmacovigilance Market is poised for continued growth and innovation.
The India Pharmacovigilance Market faces several challenges, including underreporting of adverse drug reactions due to lack of awareness and training among healthcare professionals, inadequate infrastructure and resources for pharmacovigilance activities, and a fragmented regulatory framework leading to inconsistencies in reporting standards. Additionally, the high volume of unregulated traditional and herbal medicines further complicates monitoring efforts. The lack of a centralized reporting system and poor communication between stakeholders also hinders the timely detection and management of drug safety issues. Addressing these challenges will require increased education and training programs, enhanced regulatory oversight, investment in technology and infrastructure, and improved collaboration among key stakeholders in the healthcare ecosystem.
The India Pharmacovigilance Market is primarily driven by the increasing focus on drug safety and regulatory compliance. With a growing pharmaceutical industry and rising number of adverse drug reactions, there is a heightened awareness among regulatory authorities and healthcare providers regarding the importance of pharmacovigilance activities. Additionally, the implementation of stringent regulations and guidelines by organizations such as the Central Drugs Standard Control Organization (CDSCO) and the World Health Organization (WHO) is driving the demand for pharmacovigilance services in India. The increasing adoption of advanced technologies such as artificial intelligence and data analytics for pharmacovigilance activities is also contributing to market growth by improving the efficiency and accuracy of adverse event monitoring and reporting processes.
The Indian government has implemented various policies to strengthen the pharmacovigilance market in the country. The Pharmacovigilance Program of India (PvPI) was established to monitor and report adverse drug reactions, promoting drug safety and public health. The National Coordination Centre for PvPI oversees the program`s activities, collaborating with various stakeholders including healthcare professionals, regulatory authorities, and pharmaceutical companies. Additionally, the Central Drugs Standard Control Organization (CDSCO) regulates pharmacovigilance activities, ensuring compliance with international standards and guidelines. The government`s emphasis on enhancing pharmacovigilance infrastructure and expanding reporting mechanisms aims to improve drug safety monitoring, enhance public trust in the healthcare system, and strengthen the overall pharmaceutical industry in India.
The India Pharmacovigilance Market is poised for significant growth in the coming years due to increasing regulatory requirements, rising healthcare expenditure, and the growing awareness regarding the importance of drug safety. The market is expected to benefit from the expanding pharmaceutical industry in India, which is driving the demand for pharmacovigilance services to ensure the safety and efficacy of drugs. Additionally, advancements in technology such as artificial intelligence and big data analytics are likely to enhance pharmacovigilance practices, leading to improved efficiency and effectiveness in monitoring and reporting adverse drug reactions. Overall, the India Pharmacovigilance Market is projected to experience steady growth as the country continues to focus on strengthening its healthcare infrastructure and regulatory framework.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Pharmacovigilance Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 India Pharmacovigilance Market - Industry Life Cycle |
3.4 India Pharmacovigilance Market - Porter's Five Forces |
3.5 India Pharmacovigilance Market Revenues & Volume Share, By Clinical Trial Phase, 2021 & 2031F |
3.6 India Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
3.7 India Pharmacovigilance Market Revenues & Volume Share, By Type of Reporting, 2021 & 2031F |
3.8 India Pharmacovigilance Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 India Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on patient safety and regulatory compliance |
4.2.2 Growing pharmaceutical industry in India |
4.2.3 Rising prevalence of adverse drug reactions |
4.3 Market Restraints |
4.3.1 Lack of skilled professionals in pharmacovigilance |
4.3.2 Limited awareness and understanding of pharmacovigilance practices |
4.3.3 Insufficient infrastructure and resources for effective pharmacovigilance implementation |
5 India Pharmacovigilance Market Trends |
6 India Pharmacovigilance Market, By Types |
6.1 India Pharmacovigilance Market, By Clinical Trial Phase |
6.1.1 Overview and Analysis |
6.1.2 India Pharmacovigilance Market Revenues & Volume, By Clinical Trial Phase, 2021- 2031F |
6.1.3 India Pharmacovigilance Market Revenues & Volume, By Preclinical, 2021- 2031F |
6.1.4 India Pharmacovigilance Market Revenues & Volume, By Phase I, 2021- 2031F |
6.1.5 India Pharmacovigilance Market Revenues & Volume, By Phase II, 2021- 2031F |
6.1.6 India Pharmacovigilance Market Revenues & Volume, By Phase III, 2021- 2031F |
6.1.7 India Pharmacovigilance Market Revenues & Volume, By Phase IV, 2021- 2031F |
6.2 India Pharmacovigilance Market, By Service Provider |
6.2.1 Overview and Analysis |
6.2.2 India Pharmacovigilance Market Revenues & Volume, By In-house, 2021- 2031F |
6.2.3 India Pharmacovigilance Market Revenues & Volume, By Contract Outsourcing, 2021- 2031F |
6.3 India Pharmacovigilance Market, By Type of Reporting |
6.3.1 Overview and Analysis |
6.3.2 India Pharmacovigilance Market Revenues & Volume, By Spontaneous Reporting, 2021- 2031F |
6.3.3 India Pharmacovigilance Market Revenues & Volume, By Intensified ADR Reporting, 2021- 2031F |
6.3.4 India Pharmacovigilance Market Revenues & Volume, By Targeted Spontaneous Reporting, 2021- 2031F |
6.3.5 India Pharmacovigilance Market Revenues & Volume, By Cohort Event Monitoring, 2021- 2031F |
6.3.6 India Pharmacovigilance Market Revenues & Volume, By EHR Mining, 2021- 2031F |
6.4 India Pharmacovigilance Market, By End User |
6.4.1 Overview and Analysis |
6.4.2 India Pharmacovigilance Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 India Pharmacovigilance Market Revenues & Volume, By Pharmaceutical Companies, 2021- 2031F |
6.4.4 India Pharmacovigilance Market Revenues & Volume, By Other End Users, 2021- 2031F |
7 India Pharmacovigilance Market Import-Export Trade Statistics |
7.1 India Pharmacovigilance Market Export to Major Countries |
7.2 India Pharmacovigilance Market Imports from Major Countries |
8 India Pharmacovigilance Market Key Performance Indicators |
8.1 Number of adverse drug reaction reports submitted |
8.2 Compliance rate with pharmacovigilance regulations |
8.3 Number of pharmacovigilance training programs conducted |
8.4 Utilization rate of pharmacovigilance software systems |
8.5 Efficiency of signal detection and risk assessment processes |
9 India Pharmacovigilance Market - Opportunity Assessment |
9.1 India Pharmacovigilance Market Opportunity Assessment, By Clinical Trial Phase, 2021 & 2031F |
9.2 India Pharmacovigilance Market Opportunity Assessment, By Service Provider, 2021 & 2031F |
9.3 India Pharmacovigilance Market Opportunity Assessment, By Type of Reporting, 2021 & 2031F |
9.4 India Pharmacovigilance Market Opportunity Assessment, By End User, 2021 & 2031F |
10 India Pharmacovigilance Market - Competitive Landscape |
10.1 India Pharmacovigilance Market Revenue Share, By Companies, 2024 |
10.2 India Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |